Ionic Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ionic Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-85,000	Closed	-$4.42M	–	106
2018 Q4	$4.42M	Sell	85,000 -5,000	-6%	-$269K	0.45%	28
2018 Q3	$5.59M	Sell	90,000 -135,000	-60%	-$8.01M	0.48%	32
2018 Q2	$12.5M	Buy	225,000 +56,000	+33%	+$3.02M	0.74%	16
2018 Q1	$10.7M	Hold	169,000	–	–	0.67%	27
2017 Q4	$10.4M	Buy	169,000 +15,000	+10%	+$938K	0.43%	46
2017 Q3	$9.82M	Buy	154,000 +20,000	+15%	+$1.17M	0.39%	46
2017 Q2	$7.47M	Buy	+134,000	New	+$7.29M	0.4%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ionic Capital Management's BMY Position: Q4 2019 in Review

Ionic Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 19,600 shares — an estimated $994K sold.

Ionic Capital Management first reported a position in BMY in Q1 2017 and held it in 11 quarters. The position peaked at $6.29M in Q1 2017. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

Ionic Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
Ionic Capital Management sold 19,600 Bristol-Myers Squibb shares in Q4 2019, an estimated $994K.
Ionic Capital Management first reported a position in Bristol-Myers Squibb in Q1 2017 and held it in 11 quarters.
Ionic Capital Management's Bristol-Myers Squibb position peaked at $6.29M in Q1 2017.
2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Ionic Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.